4579 ラクオリア創薬 企業サイト Yahooファイナンス 日経新聞 株探 四季報
基本データ
【業種】医薬品【市場】グロース（内国株式）
【決算期】12月
【会社設立】2008.2
【上場】2011.7
【直近決算日】2024-11-14
【決算予定日】
【時価総額】100億8400万円
【予想PER】42.71 倍
【PBR】1.79 倍
【自己資本比率】57.5 %
業績予想（通期のみ）
| 年度 | タイプ | 日付 | 売上高 | 営業利益 | 経常利益 | 純利益 |
|---|---|---|---|---|---|---|
| 2022-12 | 新規 | 2022-02-14 | 2605 | 420 | 420 | 342 |
| 修正 | 2022-11-17 | 3075(↑) | 824(↑) | 909(↑) | 724(↑) | |
| 2023-12 | 新規 | 2023-02-14 | 2799 | 260 | 242 | 183 |
| 修正 | 2023-12-08 | 1938(↓) | -409(↓) | -340(↓) | -426(↓) | |
| 2024-12 | 新規 | 2024-02-14 | 4535 | 313 | 290 | 236 |
※来期予想のグラフはQ1と表記されているがQ4である。
| 決算期 | 四半期 | 売上高 | 営業利益 | 経常利益 | 純利益 | 1株当たり純利益 | 営業利益率 | 経常利益率 | 売上高/前年比 | 営業利益/前年比 | 経常利益/前年比 | 純利益/前年比 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 予想 | 4535 | 313 | 290 | 236 | 6.9% | 6.39% | 138.5% | ― | ― | ― | ||
| 2024-12 | 3 | 2369 | -27 | -231 | -339 | -15.71 | -1.14% | -9.75% | 58.4% | ― | ― | ― |
| 2 | 1411 | -154 | -277 | -323 | -14.97 | -10.91% | -19.63% | 39.1% | ― | ― | ― | |
| 1 | 648 | 44 | -77 | -78 | -3.61 | 6.79% | -11.88% | 75.1% | ― | ― | ― | |
| 2023-12 | 4 | 1901 | -337 | -293 | -323 | -14.98 | -17.73% | -15.41% | -34.8% | ― | ― | ― |
| 3 | 1495 | -108 | -36 | -117 | -5.45 | -7.22% | -2.41% | -21.5% | ― | ― | ― | |
| 2 | 1014 | -23 | 36 | 25 | 1.18 | -2.27% | 3.55% | -29.9% | ― | -94.6% | -94.6% | |
| 1 | 370 | -108 | -110 | -148 | -6.88 | -29.19% | -29.73% | 9.2% | ― | ― | ― | |
| 2022-12 | 4 | 2918 | 866 | 904 | 723 | 34.5 | 29.68% | 30.98% | 5.1% | 22.4% | 4.7% | -4.3% |
| 3 | 1904 | 501 | 676 | 467 | 22.28 | 26.31% | 35.5% | 17.3% | 367.6% | 183.8% | 175.9% | |
| 2 | 1447 | 551 | 681 | 469 | 22.4 | 38.08% | 47.06% | 9.6% | 75.1% | 57.4% | 55% | |
| 1 | 339 | -119 | -70 | -120 | -5.77 | -35.1% | -20.65% | -48.3% | ― | ― | ― | |
| 2021-12 | 4 | 2776 | 707 | 863 | 755 | 36.07 | 25.47% | 31.09% | 150.7% | ― | ― | ― |
| 3 | 1623 | 107 | 238 | 169 | 8.08 | 6.59% | 14.66% | 183% | ― | ― | ― | |
| 2 | 1320 | 314 | 432 | 302 | 14.45 | 23.79% | 32.73% | 254.3% | ― | ― | ― | |
| 1 | 655 | 149 | 268 | 188 | 9 | 22.75% | 40.92% | 430.7% | ― | ― | ― | |
| 2020-12 | 4 | 1107 | -486 | -527 | -606 | -28.97 | -43.9% | -47.61% | -35% | ― | ― | ― |
| 3 | 573 | -600 | -615 | -698 | -33.35 | -104.71% | -107.33% | -19% | ― | ― | ― | |
| 2 | 372 | -403 | -402 | -459 | -21.93 | -108.33% | -108.06% | -31.7% | ― | ― | ― | |
| 1 | 123 | -273 | -267 | -328 | -15.66 | -221.95% | -217.07% | -64.5% | ― | ― | ― | |
| 2019-12 | 4 | 1702 | -15 | 21 | 5 | 0.26 | -0.88% | 1.23% | 128.7% | ― | ― | ― |
| 3 | 708 | -534 | -527 | -531 | -25.94 | -75.42% | -74.44% | 32.9% | ― | ― | ― | |
| 2 | 545 | -302 | -307 | -310 | -15.19 | -55.41% | -56.33% | 22.4% | ― | ― | ― | |
| 1 | 347 | -104 | -95 | -102 | -5.05 | -29.97% | -27.38% | -12.3% | ― | ― | ― | |
| 2018-12 | 4 | 744 | -1075 | -1064 | -1104 | -54.23 | -144.49% | -143.01% | -47.5% | ― | ― | ― |
| 3 | 532 | -835 | -818 | -844 | -41.47 | -156.95% | -153.76% | -12.1% | ― | ― | ― |